However, testing for differences between BRCA1-associated ER+ cancers with a retained wt BRCA1 and ER+ sporadic breast cancers would require larger numbers of these ER+ BRCA1 cancers as well as age matched ER+ sporadic controls. This evidence concerns the gene BRCA1 and breast cancer.